跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FENTANYL TRANSDERMAL SYSTEM 75 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FENTANYL TRANSDERMAL SYSTEM 75
Authorized
STANDARD
FENTANYL TRANSDERMAL SYSTEM 75
Actavis Group Ptc Ehf.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
42444e72fa845c2e
Company
Actavis Group Ptc Ehf.
Type
Standard
Approval Details
Approval Id
42444e72fa845c2e
Drug Approval Canada Name
FENTANYL TRANSDERMAL SYSTEM 75
Product Name
FENTANYL TRANSDERMAL SYSTEM 75
Status
Cancelled Pre Market
Status Date
2018-09-04
Din
02304147
Drug Class
Human
Dosage Form
Patch (Extended Release)
Route Of Administration
Transdermal
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AB03 FENTANYL
Atc Name
n 02 ab 03
Aig Number
0123302013
Company Name
Actavis Group Ptc Ehf.
Company Address
Reykjavikurvegi 78, Hafnarfjordur, Greater Reykjavik, Iceland, 220
Company Detail Path
/organization/actavis-group-ptc-ehf
Company Information
Pharmaceutical Company Name
Actavis Group Ptc Ehf.
Country Name
Norway
Province Name
buskerud,country_no
City Name
lierskogen,buskerud,country_no
Address
c/o Actavis Norway AS Gjellebekkstubben 10
Active Ingredients
FENTANYL
75 MCG / HOUR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
42444e72fa845c2e
Type
Standard
Back to Health Canada Approvals